UK Government in High-Stakes Race to Resolve Pharma Pricing Row and Secure Life Sciences Future
In an urgent bid to mend strained relationships with global pharmaceutical giants and secure the United Kingdom’s ambitions as a life sciences superpower, officials are reportedly working “day and night” to resolve a protracted Pharma Pricing Row. This significant Pharma Pricing Row has already led major companies like MSD, AstraZeneca, and Eli Lilly to pause…